J. Biochem, 1984, Vol. 96, No. 4 1079-1088
© 1984 Japanese Biochemical Society
research-article |
Characterization of Intermediate-Molecular-Weight Acid Phosphatase from Bovine Kidney Cortex
*Department of Biochemistry, Kyoto Pharmaceutical University Yamashina-ku, Kyoto, 607
**Ciba-Geigy (Japan) Limited Miyuki-cho, Takarazuka, Hyogo 665
The distribution of acid phosphatases of intermediate molecular weight was determined in various mammalian tissues. The intermediate-molecular-weight acid phosphatases (designated P-II-1 and 2) comprised about 25%of the p-nitrophenyl phosphatase activity in the supernatant of bovine kidney cortex homogenate. The P-II-1 and 2 purified 2, 000 fold showed the pI values of 5.9 and 5.7, respectively, on isoelectric focusing. Apparent molecular weights of both P-II-1 and 2 were estimated to be 42, 000 by Sephadex G-100 gel filtration and 44, 000 by SDS-polyacrylamide disc gel electrophoresis. Both the enzymes catalyzed the hydrolysis of a wide variety of natural phosphomonoesters, except for the phosphoproteins phosphoserine and o-phosphocholine. The enzymes showed a high activity on pyridoxal phosphate, ß-glycerophosphate, and 2'-AMP. The optimum activity pH was near 5 with p-itrophenyl phosphate, but was shifted to the neutral range when pyridoxal phosphate was the substrate. The cations Hg2+and Ag+had a marked inhibitory effect. Neither enzyme was inhibited significantly by L-(+)-tartrate or pCMB. The two other types of acid phosphatases, the high-molecular-weight (designated P-I) and low-molecular-weight (designated P-III, were also purified to homogeneity from bovine kidney cortex, and were compared with P-II from several aspects including substrate specificity and susceptibility to various compounds.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. P. Coburn, J. D. Mahuren, M. Jain, Y. Zubovic, and J. Wortsman Alkaline Phosphatase (EC 3.1.3.1) in Serum Is Inhibited by Physiological Concentrations of Inorganic Phosphate J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3951 - 3957. [Abstract] [Full Text] |
||||
